{"id":304659,"date":"2010-02-10T13:02:58","date_gmt":"2010-02-10T18:02:58","guid":{"rendered":"http:\/\/www.technologytransfertactics.com\/content\/?p=5873"},"modified":"2010-02-10T13:02:58","modified_gmt":"2010-02-10T18:02:58","slug":"two-new-royalty-rate-references-focus-on-medical-devices-trademarks-and-copyrights","status":"publish","type":"post","link":"https:\/\/mereja.media\/index\/304659","title":{"rendered":"Two new royalty rate references focus on medical devices, trademarks and copyrights"},"content":{"rendered":"<p>In association with IPRA Inc. and its principal, royalty rate and                valuation expert Russell Parr, 2Market Information Inc. recently                added two new royalty rate references. Both are available in print                or in PDF for immediate download.<\/p>\n<p><em><strong>Royalty Rates for Trademarks &amp; Copyrights, 4th                Edition<\/strong><\/em>, features 30% more transactions and benchmark                rates than previous editions. Along with an unrivaled set of benchmarks                and real-world rates from transactions completed through 2009, this                edition also shows how to implement financial models for the derivation                of royalty rates. Details are included on rules of thumb, profit                differential calculations, investment rate of return analyses, and                discounted cash flow analysis, along with examples that can be used                as a template for your specific applications. <a href=\"http:\/\/www.technologytransfertactics.com\/content\/ipra\/trademark-en\/\">For                details, a table of contents, sample pages, and to order, CLICK                HERE.<\/a><\/p>\n<p>With <em><strong>Royalty Rates for Technology: Medical Devices                and Diagnostics Edition<\/strong><\/em>, we\u2019ve created a targeted                reference by deriving all medical device and diagnostics entries                from the more comprehensive &#8212; and more costly &#8212; technology edition                of this unique benchmarking series. If your interest is focused                primarily on the medical device industry, you can access this valuable                data at a much lower price than the larger volume. It reports all                available compensation terms from scores of completed medical device                license agreements, gathered from more than 20 years of Mr. Parr\u2019s                research. You\u2019ll find details on fixed royalty rates, per                unit royalties, scaled royalty rates, and license fees. <a href=\"http:\/\/www.technologytransfertactics.com\/content\/ipra\/tech-med-en\/\">CLICK                HERE for more information and to order. <\/a><\/p>\n<p>All editions in the <a href=\"http:\/\/www.technologytransfertactics.com\/content\/ipra-en\/\">series<\/a> provide more than just rates and data &#8212; you get context as well.                For each transaction you\u2019ll find:<\/p>\n<ul>\n<li> A description of the licensed technology <\/li>\n<li>Compensation terms including royalty rates and license fees<\/li>\n<li> Identity of the licensor and licensee<\/li>\n<li> Transaction background and history<\/li>\n<li> Market analysis and benefits of the licensed technology<\/li>\n<\/ul>\n","protected":false},"excerpt":{"rendered":"<p>In association with IPRA Inc. and its principal, royalty rate and valuation expert Russell Parr, 2Market Information Inc. recently added two new royalty rate references. Both are available in print or in PDF for immediate download. Royalty Rates for Trademarks &amp; Copyrights, 4th Edition, features 30% more transactions and benchmark rates than previous editions. Along [&hellip;]<\/p>\n","protected":false},"author":67,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[7],"tags":[],"class_list":["post-304659","post","type-post","status-publish","format-standard","hentry","category-news"],"_links":{"self":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/posts\/304659","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/users\/67"}],"replies":[{"embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/comments?post=304659"}],"version-history":[{"count":0,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/posts\/304659\/revisions"}],"wp:attachment":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/media?parent=304659"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/categories?post=304659"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/tags?post=304659"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}